Literature DB >> 25424961

Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.

Johannes Trück1, Ruth Mitchell, Amber J Thompson, Begonia Morales-Aza, Elizabeth A Clutterbuck, Dominic F Kelly, Adam Finn, Andrew J Pollard.   

Abstract

The ELISpot assay is used in vaccine studies for the quantification of antigen-specific memory B cells (B(MEM)), and can be performed using cryopreserved samples. The effects of cryopreservation on B(MEM) detection and the consistency of cultured ELISpot assays when performed by different operators or laboratories are unknown. In this study, blood was taken from healthy volunteers, and a cultured ELISpot assay was used to count B(MEM) specific for 2 routine vaccine antigens (diphtheria and tetanus toxoid). Results were assessed for intra- and inter-operator variation, and the effects of cryopreservation. Cryopreserved samples were shipped to a second laboratory in order to assess inter-laboratory variation. B(MEM) frequencies were very strongly correlated when comparing fresh and frozen samples processed by the same operator, and were also very strongly correlated when comparing 2 operators in the same laboratory. Results were slightly less consistent when samples were processed in different laboratories but correlation between the 2 measurements was still very strong. Although cell viability was reduced in some cryopreserved samples due to higher temperatures during transportation, B(MEM) could still be quantified. These results demonstrate the reproducibility of the ELISpot assay across operators and laboratories, and support the use of cryopreserved samples in future B(MEM) studies.

Entities:  

Keywords:  B cells; ELISpot; PBMC; cryopreservation; memory B cells; shipment; storage; vaccination

Mesh:

Substances:

Year:  2014        PMID: 25424961      PMCID: PMC4896800          DOI: 10.4161/hv.29318

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  31 in total

1.  CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays.

Authors:  Christian R Kreher; Markus T Dittrich; Robert Guerkov; Bernhard O Boehm; Magdalena Tary-Lehmann
Journal:  J Immunol Methods       Date:  2003-07       Impact factor: 2.303

2.  Evaluation of Elispot assays: influence of method and operator on variability of results.

Authors:  S Janetzki; S Schaed; N E B Blachere; L Ben-Porat; A N Houghton; K S Panageas
Journal:  J Immunol Methods       Date:  2004-08       Impact factor: 2.303

3.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

4.  The impact of harmonization on ELISPOT assay performance.

Authors:  Sylvia Janetzki; Cedrik M Britten
Journal:  Methods Mol Biol       Date:  2012

5.  Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells.

Authors:  Shuya Y Kyu; James Kobie; Hongmei Yang; Martin S Zand; David J Topham; Sally A Quataert; Ignacio Sanz; F Eun-Hyung Lee
Journal:  J Immunol Methods       Date:  2008-11-06       Impact factor: 2.303

6.  Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.

Authors:  Adriana Weinberg; Lin-Ye Song; Cynthia Wilkening; Anne Sevin; Bruce Blais; Raul Louzao; Dana Stein; Patricia Defechereux; Deborah Durand; Eric Riedel; Nancy Raftery; Renee Jesser; Betty Brown; M Fran Keller; Ruth Dickover; Elizabeth McFarland; Terence Fenton
Journal:  Clin Vaccine Immunol       Date:  2009-06-10

7.  Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study.

Authors:  C A Kleeberger; R H Lyles; J B Margolick; C R Rinaldo; J P Phair; J V Giorgi
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

8.  Trypan blue exclusion test of cell viability.

Authors:  W Strober
Journal:  Curr Protoc Immunol       Date:  2001-05

9.  Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.

Authors:  Holden T Maecker; James Moon; Sonny Bhatia; Smita A Ghanekar; Vernon C Maino; Janice K Payne; Kristine Kuus-Reichel; Jennie C Chang; Amanda Summers; Timothy M Clay; Michael A Morse; H Kim Lyerly; Corazon DeLaRosa; Donna P Ankerst; Mary L Disis
Journal:  BMC Immunol       Date:  2005-07-18       Impact factor: 3.615

10.  Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).

Authors:  Sylvia Janetzki; Katherine S Panageas; Leah Ben-Porat; Jean Boyer; Cedrik M Britten; Timothy M Clay; Michael Kalos; Holden T Maecker; Pedro Romero; Jianda Yuan; W Martin Kast; Axel Hoos
Journal:  Cancer Immunol Immunother       Date:  2007-08-25       Impact factor: 6.968

View more
  14 in total

Review 1.  The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.

Authors:  Michael J Carter; Ruth M Mitchell; Patrick M Meyer Sauteur; Dominic F Kelly; Johannes Trück
Journal:  Front Immunol       Date:  2017-06-01       Impact factor: 7.561

2.  Viability and Functionality of Cryopreserved Peripheral Blood Mononuclear Cells in Pediatric Dengue.

Authors:  Federico Perdomo-Celis; Doris M Salgado; Diana M Castañeda; Carlos F Narváez
Journal:  Clin Vaccine Immunol       Date:  2016-05-06

3.  Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination.

Authors:  Victoria L Campbell; LeAnn Nguyen; Elise Snoey; Christopher L McClurkan; Kerry J Laing; Lichun Dong; Alessandro Sette; Cecilia S Lindestam Arlehamn; Danny M Altmann; Rosemary J Boyton; Justin A Roby; Michael Gale; Mars Stone; Michael P Busch; Phillip J Norris; David M Koelle
Journal:  Immunohorizons       Date:  2020-08-04

4.  Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants.

Authors:  Sonia Budroni; Francesca Buricchi; Andrea Cavallone; Patricia Bourguignon; Magalie Caubet; Vincent Dewar; Ugo D'Oro; Oretta Finco; Nathalie Garçon; Mohamed El Idrissi; Michel Janssens; Geert Leroux-Roels; Arnaud Marchant; Tino Schwarz; Pierre Van Damme; Gianfranco Volpini; Robbert van der Most; Arnaud M Didierlaurent; Wivine Burny
Journal:  NPJ Vaccines       Date:  2021-05-21       Impact factor: 7.344

5.  Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.

Authors:  John P Veluchamy; María Delso-Vallejo; Nina Kok; Fenna Bohme; Ruth Seggewiss-Bernhardt; Hans J van der Vliet; Tanja D de Gruijl; Volker Huppert; Jan Spanholtz
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

6.  Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy.

Authors:  Tom Ford; Claire Wenden; Alison Mbekeani; Len Dally; Josephine H Cox; Merribeth Morin; Nicola Winstone; Adrian V S Hill; Jill Gilmour; Katie J Ewer
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

7.  Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry.

Authors:  Bo Langhoff Hønge; Mikkel Steen Petersen; Rikke Olesen; Bjarne Kuno Møller; Christian Erikstrup
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

8.  Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.

Authors:  Anna Godi; Sara L Bissett; Elizabeth Miller; Simon Beddows
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

9.  Circulating B-lymphocytes as potential biomarkers of tuberculosis infection activity.

Authors:  Ismail Sebina; Irene A Biraro; Hazel M Dockrell; Alison M Elliott; Stephen Cose
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

10.  Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens.

Authors:  Michelle Degnin; Anupriya Agarwal; Katherine Tarlock; Soheil Meshinchi; Brian J Druker; Cristina E Tognon
Journal:  J Pediatr Hematol Oncol       Date:  2017-10       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.